News & Updates

Show Multimedia Only

No bleeding benefit to very early invasive intervention in NSTE-ACS

19 Apr 2022

Very early invasive coronary angiography does not seem to decrease the risk of serious bleedings in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), reports a recent secondary analysis of the VERDICT trial.

19 Apr 2022

Income, comorbidity predict inferior vena cava filter placement, retrieval in cancer patients

19 Apr 2022

Income and several clinical factors are associated with placement and retrieval of inferior vena cava filter for patients with cancer-related thrombosis, a study has found. In addition, filter retrieval rates remain low despite reinitiation of anticoagulation in many patients.

19 Apr 2022

Does size matter?

18 Apr 2022 by

When it comes to blood pressure (BP) cuffs, size does matter, says an expert.

18 Apr 2022

Cardiometabolic risk tied to NAFLD

16 Apr 2022

Cardiometabolic risk factors increase the risk of nonalcoholic fatty liver disease (NAFLD), though such interactions seem to vary between lean and nonlean individuals, a recent study has found.

16 Apr 2022

Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients

16 Apr 2022

In patients with type 2 diabetes, consuming fruits and engaging in physical activity can reduce the risk of all-cause, cardiovascular disease, and stroke mortality, a study reports.

16 Apr 2022

In-store nutrition education enhances adherence to DASH diet

15 Apr 2022 by

Personalized nutrition advice conducted at grocery stores led to significant improvements in DASH* diet adherence, according to findings from the SuperWIN** trial.

15 Apr 2022

GPs rank routine screening for AF as crucial as for cancers

15 Apr 2022 by

Screening for atrial fibrillation (AF) is considered to be as important as for common cancers and should be incorporated into other healthcare programmes such as flu vaccination and cancer screening programmes, based on data from the AFFECT-EU survey of GPs that was presented at EHRA 2022.

15 Apr 2022

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

15 Apr 2022

In the management of statin-treated patients with elevated cholesterol levels, the antisense oligonucleotide targeting angiopoietin-like protein 3 (ANGPTL3) vupanorsen reduces levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) and other lipid parameters, according to the results of TRANSLATE-TIMI 70.

15 Apr 2022

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

15 Apr 2022 by

Vupanorsen significantly reduces non–high-density lipoprotein cholesterol (non-HDL-C) levels in adults with hyperlipidaemia already taking statins, according to the TRANSLATE-TIMI 70* trial presented at ACC 2022.

15 Apr 2022

Aggressive BP control may ward off haemorrhagic stroke in patients with past ischaemic strokes

14 Apr 2022

Intensive blood pressure (BP) control helps reduce the risk of haemorrhagic stroke in patients with a history of ischaemic stroke, according to a post hoc analysis of the RESPECT* study.

14 Apr 2022

News & Updates

Showing Cardiology articles

Showing

Specialty:

No bleeding benefit to very early invasive intervention in NSTE-ACS

Income, comorbidity predict inferior vena cava filter placement, retrieval in cancer patients

Does size matter?

Cardiometabolic risk tied to NAFLD

Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients

In-store nutrition education enhances adherence to DASH diet

GPs rank routine screening for AF as crucial as for cancers

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

Aggressive BP control may ward off haemorrhagic stroke in patients with past ischaemic strokes